Rafferty Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Sell |
102,011
-41,661
| -29% | -$161K | ﹤0.01% | 925 |
|
|
2025
Q1 | $718K | Sell |
143,672
-14,078
| -9% | -$70.4K | ﹤0.01% | 805 |
|
|
2024
Q4 | $1.14M | Buy |
157,750
+1,964
| +1% | +$14.2K | ﹤0.01% | 768 |
|
|
2024
Q3 | $957K | Sell |
155,786
-65,805
| -30% | -$404K | ﹤0.01% | 809 |
|
|
2024
Q2 | $1.47M | Sell |
221,591
-661,037
| -75% | -$4.4M | 0.01% | 725 |
|
|
2024
Q1 | $8.99M | Buy |
+882,628
| New | +$8.99M | 0.03% | 301 |
|
|
2023
Q2 | – | Sell |
-516,563
| Closed | -$2.18M | – | 1092 |
|
|
2023
Q1 | $2.18M | Sell |
516,563
-82,324
| -14% | -$347K | 0.01% | 590 |
|
|
2022
Q4 | $9.85M | Buy |
598,887
+298,556
| +99% | +$4.91M | 0.08% | 180 |
|
|
2022
Q3 | $3.84M | Buy |
+300,331
| New | +$3.84M | 0.04% | 380 |
|
|
2022
Q1 | – | Sell |
-362,943
| Closed | -$3.33M | – | 1221 |
|
|
2021
Q4 | $3.33M | Buy |
362,943
+198,865
| +121% | +$1.82M | 0.02% | 514 |
|
|
2021
Q3 | $1.86M | Sell |
164,078
-17,444
| -10% | -$197K | 0.01% | 657 |
|
|
2021
Q2 | $1.79M | Sell |
181,522
-17,276
| -9% | -$170K | 0.01% | 717 |
|
|
2021
Q1 | $2.81M | Buy |
+198,798
| New | +$2.81M | 0.02% | 529 |
|